Association of endothelial nitric oxide synthase gene polymorphisms with end-stage renal disease: a systematic review and meta-analysis

References

• Sowjanya B, Sreenivasulu U, Naidu JN, Sivaranjani N. End stage renal disease, differential diagnosis, a rare genetic disorder: Bardet-Biedl syndrome: case report and review. Indian J Clin Biochem. 2011;26(2):214–216
   PubMedGoogle Scholar
• Kuo CC, Lee CT, Ho SC, Kuo HW, Wu TN, Yang CY. Hemodialysis and the risk of stroke: a population-based cohort study in Taiwan, a country of high incidence of end-stage renal disease. Nephrology (Carlton). 2012;17(3):243–248
   PubMed Web of Science ®Google Scholar
• Halen NV, Cukor D, Constantiner M, Kimmel PL. Depression and mortality in end-stage renal disease. Curr Psychiatry Rep. 2012;14(1):36–44
   PubMed Web of Science ®Google Scholar
• Gilbertson DT, Liu J, Xue JL, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol. 2005;16(12):3736–3741
   PubMed Web of Science ®Google Scholar
• Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med. 2009;169(4):342–350
   PubMed Web of Science ®Google Scholar
• Zhou TB, Yin SS. Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism with the risk of end-stage renal disease. Ren Fail. 2013;35(4):573–578
   PubMed Web of Science ®Google Scholar
• Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327(6122):524–526
   PubMed Web of Science ®Google Scholar
• Stuehr DJ. Structure-function aspects in the nitric oxide synthases. Annu Rev Pharmacol Toxicol. 1997;37:339–359
   PubMed Web of Science ®Google Scholar
• Marsden PA, Heng HH, Scherer SW, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993;268(23):17478–17488
   PubMed Web of Science ®Google Scholar
• Forstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33(7):829–837, 837a–837d
   PubMed Web of Science ®Google Scholar
• Nakayama M, Yasue H, Yoshimura M, et al. T-786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 1999;99(22):2864–2870
   PubMed Web of Science ®Google Scholar
• Lamblin N, Cuilleret FJ, Helbecque N, et al. A common variant of endothelial nitric oxide synthase (Glu298Asp) is associated with collateral development in patients with chronic coronary occlusions. BMC Cardiovasc Disord. 2005;5:27
   PubMedGoogle Scholar
• Wang XL, Mahaney MC, Sim AS, et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol. 1997;17(11):3147–3153
   PubMed Web of Science ®Google Scholar
• Suzuki H, Nagase S, Kikuchi S, Wang Y, Koyama A. Association of a missense Glu298Asp mutation of the endothelial nitric oxide synthase gene with end stage renal disease. Clin Chem. 2000;46(11):1858–1860
   PubMed Web of Science ®Google Scholar
• Walker D, Consugar M, Slezak J, et al. The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1. Am J Kidney Dis. 2003;41(1):90–94
   PubMed Web of Science ®Google Scholar
• Tang FY, Liu FY, Xie XW. Association of angiotensin-converting enzyme and endothelial nitric oxide synthase gene polymorphisms with vascular disease in ESRD patients in a Chinese population. Mol Cell Biochem. 2008;319(1–2):33–39
   PubMed Web of Science ®Google Scholar
• Lin S, Qu H, Qu M, Yang X. Association of ecNOS4b/a polymorphism and end-stage chronic renal failure. Chin J Internal Med. 2002;41:513–516
   PubMedGoogle Scholar
• Marson BP, Dickel S, Ishizawa MH, et al. Endothelial nitric oxide genotypes and haplotypes are not associated with end-stage renal disease. DNA Cell Biol. 2011;30(1):55–59
   PubMed Web of Science ®Google Scholar
• Bellini MH, Figueira MN, Piccoli MF, et al. Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease. Nephrology (Carlton). 2007;12(3):289–293
   PubMed Web of Science ®Google Scholar
• Kerkeni M, Letaief A, Achour A, Miled A, Trivin F, Maaroufi K. Endothelial nitric oxide synthetase, methylenetetrahydrofolate reductase polymorphisms, and cardiovascular complications in Tunisian patients with nondiabetic renal disease. Clin Biochem. 2009;42(10–11):958–964
   PubMed Web of Science ®Google Scholar
• Tripathi G, Sharma RK, Baburaj VP, Sankhwar SN, Jafar T, Agrawal S. Genetic risk factors for renal failure among north Indian ESRD patients. Clin Biochem. 2008;41(7–8):525–531
   PubMed Web of Science ®Google Scholar
• Thaha M, Pranawa, Yogiantoro M, et al. Association of endothelial nitric oxide synthase Glu298Asp polymorphism with end-stage renal disease. Clin Nephrol. 2008;70(2):144–154
   PubMed Web of Science ®Google Scholar
• Nagase S, Suzuki H, Wang Y, et al. Association of ecNOS gene polymorphisms with end stage renal diseases. Mol Cell Biochem. 2003;244(1–2):113–118
   PubMed Web of Science ®Google Scholar
• Noiri E, Satoh H, Taguchi J, et al. Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension. 2002;40(4):535–540
   PubMed Web of Science ®Google Scholar
• Asakimori Y, Yorioka N, Taniguchi Y, et al. T(-786)→C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease. Nephron. 2002;91(4):747–751
   PubMed Web of Science ®Google Scholar
• Asakimori Y, Yorioka N, Yamamoto I, et al. Endothelial nitric oxide synthase intron 4 polymorphism influences the progression of renal disease. Nephron. 2001;89(2):219–223
   PubMed Web of Science ®Google Scholar
• Buraczynska M, Ksiazek P, Zaluska W, Nowicka T, Ksiazek A. Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease. Nephrol Dial Transplant. 2004;19(9):2302–2306
   PubMed Web of Science ®Google Scholar
• Lamnissou K, Zirogiannis P, Trygonis S, et al. Evidence for association of endothelial cell nitric oxide synthase gene polymorphism with earlier progression to end-stage renal disease in a cohort of Hellens from Greece and Cyprus. Genet Test. 2004;8(3):319–324
   PubMedGoogle Scholar
• El-Din Bessa SS, Hamdy SM. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients. Ren Fail. 2011;33(9):878–884
   PubMed Web of Science ®Google Scholar
• de Prado A, Donate T, Martinez E, et al. Endothelial nitric oxide synthase gene polymorphism in dialysis patients. Adv Perit Dial. 2002;18:18–20
   PubMedGoogle Scholar
• Zsom M, Fulop T, Zsom L, Barath A, Maroti Z, Endreffy E. Genetic polymorphisms and the risk of progressive renal failure in elderly Hungarian patients. Hemodial Int. 2011;15(4):501–508
   PubMed Web of Science ®Google Scholar
• Ulrich C, Heine GH, Seibert E, Fliser D, Girndt M. Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease. Nephrol Dial Transplant. 2010;25(7):2265–2272
   PubMed Web of Science ®Google Scholar
• Sharma R, Agrawal S, Saxena A, Pandey M, Sharma RK. Association of genetic variants of ghrelin, leptin and UCP2 with malnutrition inflammation syndrome and survival in end-stage renal disease patients. Genes Nutr. 2013;8(6):611–621
   PubMed Web of Science ®Google Scholar
• Kajimoto H, Kai H, Aoki H, et al. Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine. Kidney Int. 2012;81(8):762–768
   PubMed Web of Science ®Google Scholar
• Jensen FB. The role of nitrite in nitric oxide homeostasis: a comparative perspective. Biochim Biophys Acta. 2009;1787(7):841–848
   PubMed Web of Science ®Google Scholar
• Figueroa XF, Lillo MA, Gaete PS, Riquelme MA, Saez JC. Diffusion of nitric oxide across cell membranes of the vascular wall requires specific connexin-based channels. Neuropharmacology. 2013;75:471–478
   PubMed Web of Science ®Google Scholar
• Umar S, van der Laarse A. Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart. Mol Cell Biochem. 2010;333(1–2):191–201
   PubMed Web of Science ®Google Scholar
• Song J, Yoon Y, Park KU, et al. Genotype-specific influence on nitric oxide synthase gene expression, protein concentrations, and enzyme activity in cultured human endothelial cells. Clin Chem. 2003;49(6 Pt 1):847–852
   PubMed Web of Science ®Google Scholar
• Tsukada T, Yokoyama K, Arai T, et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun. 1998;245(1):190–193
   PubMed Web of Science ®Google Scholar
• Andersen ML, Guindalini C, Santos-Silva R, Bittencourt LR, Tufik S. Association analysis of endothelial nitric oxide synthase G894T gene polymorphism and erectile dysfunction complaints in a population-based survey. J Sex Med. 2010;7(3):1229–1236
   PubMed Web of Science ®Google Scholar
• Joshi MS, Mineo C, Shaul PW, Bauer JA. Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear. FASEB J. 2007;21(11):2655–2663
   PubMed Web of Science ®Google Scholar
• Su MT, Lin SH, Chen YC. Genetic association studies of angiogenesis- and vasoconstriction-related genes in women with recurrent pregnancy loss: a systematic review and meta-analysis. Hum Reprod Update. 2011;17(6):803–812
   PubMed Web of Science ®Google Scholar
• Yu CK, Casas JP, Savvidou MD, Sahemey MK, Nicolaides KH, Hingorani AD. Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis. BMC Pregnancy Childbirth. 2006;6:7
   PubMedGoogle Scholar
• Nakayama M, Yasue H, Yoshimura M, et al. T(-786)→ C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. Am J Cardiol. 2000;86(6):628–634
   PubMed Web of Science ®Google Scholar